Remote possibilities: United BioSource teams with Seqster to boost decentralized study offering
Remote possibilities: United BioSource teams with Seqster to boost decentralized [...]
Pfizer’s $130M Lyme disease vaccine advances to phase 3 after 3rd shot shown to increase antibodies
Pfizer’s $130M Lyme disease vaccine advances to phase 3 after [...]
Unity once again lays off large number of staff, narrows focus to ophthalmology assets
Unity once again lays off large number of staff, narrows [...]
Arrowhead ‘changing horses’ for ENaC pulmonary program as phase 1/2 asset shelved
Arrowhead ‘changing horses’ for ENaC pulmonary program as phase 1/2 [...]
Pfizer accuses former employees of ‘treachery’ in stealing trade secrets to form Regor Therapeutics
Pfizer accuses former employees of ‘treachery’ in stealing trade secrets [...]
Roche lets go of etro, dumping phase 3 Crohn’s prospect 18 months after posting weak colitis data
Roche lets go of etro, dumping phase 3 Crohn’s prospect [...]
AstraZeneca punts midphase cardiovascular prospect to startup
AstraZeneca punts midphase cardiovascular prospect to startup ntaylor Thu, 02/03/2022 [...]
Gilead’s CD47 clinical hold expands as CEO O’Day expresses ‘sense of urgency’ in getting trials back on track
Gilead’s CD47 clinical hold expands as CEO O’Day expresses ‘sense [...]
FDA puts LogicBio genome editing therapy trial on hold after 2nd infant suffers adverse event
FDA puts LogicBio genome editing therapy trial on hold after [...]
Novartis JAKs in rival to Incyte’s topical eczema drug after seeing clinical data
Novartis JAKs in rival to Incyte’s topical eczema drug after [...]